[1] Bruix J, Gores GJ, Mazzaferro V.Hepatocellular carcinoma: clinical frontiers and perspectives[J]. Gut,2014,63(5):844-855. [2] Forner A, Llovet JM, Bruix J.Hepatocellular carcinoma[J]. Lancet,2012,379(9822):1245-1255. [3] Bruix J, Sherman M, American Association for the Study of Liver Disease. Management of hepatocellular carcinoma: an update[J]. Hepatology,2011,53(3):1020-1022. [4] European Association for the Study of the Liver, European Organisation for Research, Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol,2012,56(4):908-943. [5] Zhong JH, Ke Y, Gong WF, et al.Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma[J]. Ann Surg,2014,260(2):329-340. [6] Sakamoto K, Nagano H.Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus[J]. Hepatol Res,2017,47(10):957-962. [7] Torzilli G, Belghiti J, Kokudo N, et al.A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? an observational study of the HCC East-West study group[J]. Ann Surg,2013,257(5):929-937. [8] Yang T, Lin C, Zhai J, et al.Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging[J]. J Cancer Res Clin Oncol,2012,138(7):1121-1129. [9] Grimm RH Jr, Neaton JD, Ludwig W.Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality[J]. JAMA,1985,254(14):1932-1937. [10] Shankar A, Wang JJ, Rochtchina E, et al.Association between circulating white blood cell count and cancer mortality: a population-based cohort study[J]. Arch Intern Med,2006,166(2):188-194. [11] Erlinger TP, Muntner P, Helzlsouer KJ.WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study[J]. Cancer Epidemiol Biomarkers Prev,2004,13(6):1052-1056. [12] Jee SH, Park JY, Kim HS, et al.White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans[J]. Am J Epidemiol,2005,162(11):1062-1069. [13] Huang W, Wang F, Li Y, et al.Leukemoid reaction in sarcomatoid renal cell carcinoma: a two-case report[J]. World J Surg Oncol,2014,12:100. [14] Riesenberg H, Muller F, Gorner M.Leukemoid reaction in a patient with adenocarcinoma of the lung: a case report[J]. J Med Case Rep,2012,6:211. [15] Coffelt SB, De Visser KE.Cancer: Inflammation lights the way to metastasis[J]. Nature,2014,507(7490):48-49. [16] Colotta F, Allavena P, Sica A, et al.Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability[J]. Carcinogenesis,2009,30(7):1073-1081. [17] Solinas G, Marchesi F, Garlanda C, et al.Inflammation-mediated promotion of invasion and metastasis[J]. Cancer Metastasis Rev,2010,29(2):243-248. |